Minimum effective concentration of sevoflurane for I-gel laryngeal mask insertion in children

Phase 4, open-label, single-arm trial of sevoflurane in inguinal hernia, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: 50% minimum effective concentration of sevoflurane for successful I-gel insertion and 90% minimum effective concentration of sevoflurane for successful I-gel insertion. Planned start Dec 2022; status: not yet recruiting.